WASHINGTON D.C.: As January marks Cervical Health Awareness Month, the American Cancer Society has updated its screening guidelines to improve early detection and prevention of cervical cancer for 2026. Cervical cancer remains a leading health concern, with about 13,000 new cases diagnosed and approximately 4,000 deaths each year in the United States. This emphasizes the critical need for effective prevention strategies and accessible screening procedures.

The updated guidelines recommend that individuals begin cervical cancer screening at age 21 with traditional pap smears. Beginning at age 25, HPV-based testing is suggested every five years until the age of 65. A significant change is the FDA's approval of self-collected HPV testing, providing a convenient alternative to traditional clinic-based exams, though clinician-based screening is still preferred. These recommendations aim to address the plateauing rates in cervical cancer diagnoses, which have remained stagnant despite a significant reduction in incidence since the 1970s.

Notably, the American Society for Colposcopy and Cervical Pathology advises patients to follow up with colposcopy, biopsy, or loop electrosurgical excision for abnormal test results to mitigate the progression of the disease. With advancements in treatment, patients diagnosed with early-stage cervical cancer have more options available, including less invasive procedures aimed at preserving fertility. Meanwhile, for those with more advanced stages, combined chemotherapy and radiation therapies show promise, offering hope for improved survival rates.

As healthcare systems mobilize efforts for early detection this year, institutions like Newport Women’s Health announce new providers and comprehensive services for women’s health, encouraging women to prioritize their cervical health. With new treatments on the horizon and a focus on patient-centered care, there is optimism in reducing the burden of cervical cancer in the coming years.